Skip to main content
Hempfusion Wellness Inc. logo

Hempfusion Wellness Inc. — Investor Relations & Filings

Ticker · CBDHF ISIN · CA4238211078 LEI · 549300IKC8T8NTH4GY17 TSX Manufacturing
Open in API
Filings indexed 102 across all filing types
Latest filing 2023-06-23 Legal Proceedings Report
Country CA Canada
Listing TSX CBDHF

About Hempfusion Wellness Inc.

https://www.hempfusion.com/

Hempfusion Wellness Inc. is a health and wellness supplement company specializing in the manufacturing, marketing, and sale of hemp-derived Cannabidiol (CBD) and probiotic products. The company utilizes whole-food hemp nutrition and superior extraction methods to produce broad-spectrum CBD formulations. Its product portfolio includes tinctures, capsules, gummies, and topical creams and gels. Hempfusion distributes its offerings under a family of premium consumer brands, notably HempFusion , Sagely Naturals , and Apothecanna. The company focuses on providing best-in-class CBD solutions within the health and wellness space.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Legal Proceedings Report Classification · 95% confidence The document is an announcement regarding HempFusion Wellness Inc. entering bankruptcy and obtaining creditor protection under Canada's Bankruptcy and Insolvency Act. It describes the cessation of operations, termination of employees, and the establishment of a trustee to manage the bankruptcy process. There is no financial data, detailed financial statements, or regulatory filings typical of annual or interim reports. The document is a formal announcement about a significant legal and financial event (bankruptcy) affecting the company. This fits best under Legal Proceedings Report (LTR), which covers updates on significant lawsuits, regulatory actions, or legal matters involving the company.
2023-06-23 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short announcement (2418 characters) stating that HempFusion will not proceed with a proposed transaction with GABY Inc. It also mentions ceasing operations, employee terminations, and exploring bankruptcy options. There is no detailed financial data, no full report, no regulatory form references, and no detailed management discussion. The document is clearly an announcement about a transaction cancellation and company status update, not a full merger filing or financial report. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2023-06-02 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release from HempFusion Wellness Inc. discussing the company's ongoing efforts to file its annual audited financial statements for the year ended December 31, 2021, along with related annual information forms, interim financial reports, management's discussion and analysis, and CEO and CFO certificates. It also mentions the Toronto Stock Exchange (TSX) reviewing the company for continued listing compliance and the granted deadline to regain compliance. The document does not contain the actual financial statements or detailed financial data but rather an update on the status of these filings and regulatory compliance. It is a regulatory announcement informing investors about the delay and the company's remedial actions. The document length is 6262 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the rules, this document should be classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the full annual report or interim report itself.
2022-12-12 English
Other.PDF
Regulatory Filings
2022-12-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the sale of a business segment (Probulin Biotics) and providing an update on the company's CTO and its upcoming Annual General Meeting (AGM). It mentions the company's intention to file required financial reports and hold the AGM by a certain date but does not contain any actual financial statements or detailed financial performance data. The document also discusses regulatory and listing status updates and forward-looking statements. It is not a full Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is not a direct AGM Information document (AGM-R) because it does not contain AGM materials or presentations but rather an announcement about the AGM timing and related corporate updates. The document is primarily an announcement about corporate events and regulatory filing status, which fits best under Regulatory Filings (RNS) as a general regulatory announcement and update. The document length (8074 characters) is sufficient to contain substantive information but lacks detailed financial data or report content. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-11-23 English
News release - English.pdf
AGM Information Classification · 95% confidence The document is an announcement regarding the extension of the deadline to hold the company's 2022 Annual General Meeting (AGM). It does not contain the AGM materials or presentations themselves, nor does it include financial data or voting results. The document is short (2250 characters) and serves as an update about the timing of the AGM. Therefore, it is best classified as AGM Information (AGM-R), which covers presentations and materials shared during or about the AGM, including updates related to the AGM schedule.
2022-07-13 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.